Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Water-soluble tomato concentrate (WSTC) is a natural extract derived from ripe tomatoes (*Lycopersicon esculentum*) by removing fat-soluble components and insoluble material. It is substantially free of lycopene and primarily contains compounds such as adenosine, chlorogenic acid, and rutin[3][4]. WSTC has demonstrated antiplatelet effects by inhibiting ADP- or collagen-induced platelet activation and aggregation in vitro and in vivo[4][5]. Clinical studies have shown that supplementation with WSTC can lower blood pressure, improve cardiovascular risk profiles in hypercholesterolemic individuals, reduce plasma triglyceride levels, and modulate inflammatory responses[1][2][3]. Its mechanism of action involves the inhibition of platelet function through multiple pathways without significantly increasing bleeding risk. The product is marketed under the brand name Fruitflow.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on water-soluble tomato concentrate.